These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10204813)

  • 1. Ambulatory blood pressure profiles in essential hypertensives after treatment with a new once daily nifedipine formulation.
    Nold G; Herholz C; Sturm M; Hopf R; Lemmer B
    J Hum Hypertens; 1999 Mar; 13(3):173-7. PubMed ID: 10204813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study.
    Bonaduce D; Canonico V; Petretta M; Forgione L; Ianniciello A; Cavallaro V; Bertocchi F; Rengo F
    Eur J Clin Pharmacol; 1997; 53(2):95-100. PubMed ID: 9403278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive agents on circadian blood pressure in hypertensive patients with previous brain infarction.
    Azuma T; Matsubara T; Nagai Y; Funauchi M; Fujimoto T; Saito T; Tone K; Sakoda S
    J Hum Hypertens; 1997 Oct; 11(10):637-40. PubMed ID: 9400905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists, a useful additional therapy in treatment resistant hypertension: comparison of felodipine ER and nifedipine Retard by 24-h ambulatory blood pressure monitoring.
    Dees A; Kremer Hovinga T; Breed JG; Verstappen VM; Puister SM; Meems L
    Neth J Med; 1997 Jan; 50(1):2-12. PubMed ID: 9038037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of circadian amplitude and chronotherapy: relevance to prevention and treatment of stroke.
    Shinagawa M; Kubo Y; Otsuka K; Ohkawa S; Cornélissen G; Halberg F
    Biomed Pharmacother; 2001; 55 Suppl 1():125s-132s. PubMed ID: 11774859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A
    J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-over comparison of nifedipine Oros and felodipine extended release with blind 24 h ambulatory blood pressure assessments.
    Taverner D; Marley J; Tonkin AL
    Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):909-13. PubMed ID: 10561813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of daily anti-hypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring - utility of "hypobaric curve" and "hypobaric area".
    Kuga K; Xu DZ; Ohtsuka M; Aonuma K; Lau AH; Watanabe Y; Ohtsuka K
    Clin Exp Hypertens; 2011; 33(4):231-9. PubMed ID: 21699449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group.
    Zidek W; Spiecker C; Knaup G; Steindl L; Breuer HW
    Clin Ther; 1995; 17(4):686-700. PubMed ID: 8565032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Mancia G; Omboni S; Parati G;
    J Hypertens; 2002 Mar; 20(3):545-53. PubMed ID: 11875324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
    Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
    Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
    Isles CG; Kitchin NR
    J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
    Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of slow release nifedipine tablets in patients with essential hypertension.
    Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H
    Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension.
    Pivac N; Naranca M; Vujic-Podlipec D; Bagatin J; Rumboldt Z
    Arzneimittelforschung; 2002; 52(5):379-84. PubMed ID: 12087923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.
    Greminger P; Suter PM; Holm D; Kobelt R; Vetter W
    Clin Investig; 1994 Nov; 72(11):864-9. PubMed ID: 7894213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.